Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex
- PMID: 30104265
- PMCID: PMC6153851
- DOI: 10.1128/AAC.01105-18
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex
Abstract
Mycobacterium avium complex (MAC) and M. abscessus complex (MABC) comprise the two most important human pathogen groups causing nontuberculous mycobacterial lung disease (NTM-LD). However, there are limited data regarding NTM-LD caused by mixed NTM infections. This study aimed to evaluate the clinical characteristics and treatment outcomes in patients with NTM-LD caused by mixed infection with these two major NTM pathogen groups. Seventy-one consecutive patients who had been diagnosed with NTM-LD caused by mixed infection with MAC (M. avium or M. intracellulare) and MABC (M. abscessus or M. massiliense) between January 2010 and December 2015 were identified. Nearly all patients (96%) had the nodular bronchiectatic form of NTM-LD. Mixed infection with MAC and M. massiliense (n = 47, 66%) was more common than mixed infection with MAC and M. abscessus (n = 24, 34%), and among the 43 (61%) patients who were treated for NTM-LD for more than 12 months, sputum culture conversion rates were significantly lower in patients infected with MAC and M. abscessus (25% [3/12]) than in patients infected with MAC and M. massiliense (61% [19/31, P = 0.033]). Additionally, M. massiliense and M. abscessus showed marked differences in clarithromycin susceptibility (90% versus 6%, P < 0.001). Of the 23 patients who successfully completed treatment, 11 (48%) redeveloped NTM lung disease, with mycobacterial genotyping results indicating that the majority of cases were due to reinfection. Precise identification of etiologic NTM organisms could help predict treatment outcomes in patients with NTM-LD due to mixed infections.
Keywords: Mycobacterium abscessus; Mycobacterium avium complex; coinfection; nontuberculous mycobacteria.
Copyright © 2018 American Society for Microbiology.
Figures
Similar articles
-
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00011-18. doi: 10.1128/AAC.00011-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29661870 Free PMC article.
-
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.J Korean Med Sci. 2016 May;31(5):649-59. doi: 10.3346/jkms.2016.31.5.649. Epub 2016 Mar 22. J Korean Med Sci. 2016. PMID: 27134484 Free PMC article. Review.
-
Implication of species change of Nontuberculous Mycobacteria during or after treatment.BMC Pulm Med. 2017 Dec 20;17(1):213. doi: 10.1186/s12890-017-0539-7. BMC Pulm Med. 2017. PMID: 29262802 Free PMC article.
-
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.J Clin Microbiol. 2019 Jul 26;57(8):e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug. J Clin Microbiol. 2019. PMID: 31167842 Free PMC article.
-
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8. Respir Med. 2019. PMID: 31128614 Review.
Cited by
-
Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex.PLoS One. 2022 Jul 21;17(7):e0271660. doi: 10.1371/journal.pone.0271660. eCollection 2022. PLoS One. 2022. PMID: 35862353 Free PMC article.
-
Species Typing of Nontuberculous Mycobacteria by Use of Deoxyribozyme Sensors.Clin Chem. 2019 Feb;65(2):333-341. doi: 10.1373/clinchem.2018.295212. Epub 2018 Dec 6. Clin Chem. 2019. PMID: 30523201 Free PMC article.
-
Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.J Korean Med Sci. 2024 May 27;39(20):e167. doi: 10.3346/jkms.2024.39.e167. J Korean Med Sci. 2024. PMID: 38804011 Free PMC article.
-
Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients.Antibiotics (Basel). 2020 Nov 2;9(11):771. doi: 10.3390/antibiotics9110771. Antibiotics (Basel). 2020. PMID: 33147819 Free PMC article. Review.
-
Risk Factors and Mental Health Status in Patients With Non-Tuberculous Mycobacterial Lung Disease: A Single Center Retrospective Study.Front Public Health. 2022 Aug 1;10:912651. doi: 10.3389/fpubh.2022.912651. eCollection 2022. Front Public Health. 2022. PMID: 35979468 Free PMC article.
References
-
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416. doi:10.1164/rccm.200604-571ST. - DOI - PubMed
-
- Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S. 2017. A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013. Ann Am Thorac Soc 14:49–56. doi:10.1513/AnnalsATS.201607-573OC. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
